652 papers
Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.
At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.
Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.
This study demonstrates that recombinant dimeric Platelet Factor 4 (rdPF4) acts as a cationic opsonin that binds to the negatively charged capsule of *Klebsiella pneumoniae*, thereby enhancing CR3-mediated phagocytosis and significantly improving bacterial clearance and survival in a mouse sepsis model.
This study reveals that in *Streptococcus pneumoniae*, the non-cognate sensor kinase VncS promotes host cell adhesion by cross-phosphorylating and activating the response regulator RR06 to upregulate the adhesin CbpA, a process normally restrained by the cognate kinase HK06 acting as a phosphatase.
This study demonstrates that seed-applied multi-kingdom synthetic communities can effectively colonize *Brassica napus* seedlings and reshape native microbiota, revealing that selecting ecologically relevant strains with specific traits like high seed abundance and low lag-time is more critical for success than the specific assembly strategy used.
Using a *Caenorhabditis elegans* model, this study demonstrates that treating *Pseudomonas aeruginosa* PA14 infections with specific bacteriophages does not alter the composition of the native gut microbiome, supporting the safety of phage therapy regarding microbiome disruption.
In corn monoculture soils, the retention of plant residue selectively enriches antagonistic phenotypes among lignin-degrading *Streptomyces* due to competition for lignin breakdown products, whereas non-degrading isolates show no such treatment-dependent shift in antagonism.
By analyzing metagenomic data from two contrasting French coastal sites, this study reveals distinct seasonal succession patterns of Synechococcus pigment types driven by light spectral niches and water color, highlighting how pigment diversity shapes the spatiotemporal distribution of these cyanobacteria.
This study characterizes MTB-LysB1, a novel mycobacteriophage-derived endolysin that effectively targets multidrug-resistant *Mycobacterium tuberculosis* at nanomolar concentrations and enhances the efficacy of standard antibiotics by disrupting the bacterial cell wall, positioning it as a promising next-generation adjunct therapy for tuberculosis.
This study elucidates the structural basis of *Pseudomonas aeruginosa* biofilm formation by determining the cryo-EM structure of the CdrA adhesin's conserved ADEPT domain, demonstrating its essential role in bacterial aggregation and validating it as a target for inhibitory nanobodies and mutagenesis to disrupt pathogenic biofilms.
mAIcrobe is an open-source, napari-based framework that integrates deep learning models to enable accessible, high-throughput, and reproducible quantitative analysis of diverse bacterial morphologies and phenotypes for the broader microbiology community.
This study demonstrates that the vertical transmission of maternal Lactobacillaceae during early life is critical for establishing resistance to cholera, as these bacteria inhibit *Vibrio cholerae* colonization through acidification, while their disruption by maternal antibiotics prolongs susceptibility to the disease.